BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7909227)

  • 21. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
    Iuliano R; Forastieri G; Brizzi M; Mecocci L; Mazzotta F; Ceccherini-Nelli L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(5):408-14. PubMed ID: 9170414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment.
    Ferre F; Marchese AL; Griffin SL; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
    AIDS; 1993 Nov; 7 Suppl 2():S21-7. PubMed ID: 8161442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.
    de Mendoza C; Lu W; Machuca A; Sainz M; Castilla J; Soriano V
    J Med Virol; 2001 Jul; 64(3):217-22. PubMed ID: 11424107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa.
    Bonard D; Rouet F; Toni TA; Minga A; Huet C; Ekouévi DK; Dabis F; Salamon R; Rouzioux C;
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):267-73. PubMed ID: 14600570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of human immunodeficiency virus by culture and polymerase chain reaction in response to didanosine after long-term therapy with zidovudine.
    Katzenstein DA; Winters M; Bubp J; Israelski D; Winger E; Merigan TC
    J Infect Dis; 1994 Feb; 169(2):416-9. PubMed ID: 7906292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
    JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments.
    Bruisten SM; Koppelman MH; Roos MT; Loeliger AE; Reiss P; Boucher CA; Huisman HG
    AIDS; 1993 Nov; 7 Suppl 2():S15-20. PubMed ID: 8161441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
    Science; 1993 Mar; 259(5102):1749-54. PubMed ID: 8096089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment.
    Stellbrink HJ; Zöller B; Fenner T; Lichtenberg G; van Lunzen J; Albrecht H; Thiele HG; Greten H
    AIDS; 1996 Jul; 10(8):849-57. PubMed ID: 8828742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease.
    Verhofstede C; Reniers S; Van Wanzeele F; Plum J
    AIDS; 1994 Oct; 8(10):1421-7. PubMed ID: 7529507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.
    Saag MS; Crain MJ; Decker WD; Campbell-Hill S; Robinson S; Brown WE; Leuther M; Whitley RJ; Hahn BH; Shaw GM
    J Infect Dis; 1991 Jul; 164(1):72-80. PubMed ID: 1676046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal and short-term stability of HIV virus load as measured by gene amplification.
    Holodniy M; Mole L; Winters M; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):363-8. PubMed ID: 7907661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New technologies for quantifying HIV: amplification assays directly measure the virus at all stages of infection.
    J Int Assoc Physicians AIDS Care; 1995 Nov; 1(10):14-5. PubMed ID: 11362970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
    Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of a standardized reverse-transcriptase PCR assay for quantifying HIV-1 RNA in plasma and serum.
    Izopet J; Poggi C; Dussaix E; Mansuy JM; Cubaynes L; Profizi N; Lafeuillade A; Marchou B; Massip P; Sayada C; Puel J
    J Virol Methods; 1996 Jul; 60(2):119-29. PubMed ID: 8844617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of HIV-1 cell-free viremia.
    Henrard DR; Phillips JF; Muenz LR; Blattner WA; Wiesner D; Eyster ME; Goedert JJ
    JAMA; 1995 Aug; 274(7):554-8. PubMed ID: 7629984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease. A retrospective, longitudinal study of vertically acquired human immunodeficiency virus type 1 infection in children.
    Zaknun D; Orav J; Kornegay J; al-Attar I; Fuchs D; Zaknun J; Wachter H; Chatis P; Burchett SK; McIntosh K
    J Pediatr; 1997 Jun; 130(6):898-905. PubMed ID: 9202611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.
    Ercoli L; Sarmati L; el-Sawaf G; Cochi S; Lanti T; Iudicone P; Guglielmetti M; Giannini G; Galluzzo C; Tomino C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1203-7. PubMed ID: 8573376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.